Psychedelic treatment is still in the early stages of clinical research and is not yet widely approved by regulatory agencies. Consequently, clinics offering psychedelic treatments, like Mindbloom, apply specific screening criteria to determine if a client is a suitable candidate.

A client may receive conditional approval for psychedelic treatment if they generally meet the criteria but also have certain factors that could impact the treatment’s safety or effectiveness. For example, a client with a history of severe mental illness or medical conditions that might be affected by psychedelic treatment may be conditionally approved if they agree to additional precautions or extra monitoring during their treatment.